Induction of AMPK activation by N,N’-Diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers

التفاصيل البيبلوغرافية
العنوان: Induction of AMPK activation by N,N’-Diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
المؤلفون: Vitaliy M. Sviripa, Heidi L. Weiss, B. Mark Evers, Piotr G. Rychahou, Chunming Liu, Jeremy Johnson, David S. Watt
المصدر: PLoS ONE
PLoS ONE, Vol 14, Iss 3, p e0209392 (2019)
بيانات النشر: Cold Spring Harbor Laboratory, 2018.
سنة النشر: 2018
مصطلحات موضوعية: 0301 basic medicine, Carcinogenesis, Cancer Treatment, Estrogen receptor, Apoptosis, Triple Negative Breast Neoplasms, AMP-Activated Protein Kinases, Biochemistry, 0302 clinical medicine, Animal Cells, Cancer Stem Cells, Breast Tumors, Medicine and Health Sciences, Cyclin D1, Cell Cycle and Cell Division, Post-Translational Modification, Phosphorylation, Triple-negative breast cancer, Ribosomal Protein S6, 0303 health sciences, Multidisciplinary, Cell Death, Chemistry, Stem Cells, Stem Cell Therapy, Cell cycle, 3. Good health, Gene Expression Regulation, Neoplastic, Oncology, Receptors, Estrogen, Cell Processes, 030220 oncology & carcinogenesis, Ribosomal protein s6, MCF-7 Cells, Medicine, Female, Cellular Types, Poly(ADP-ribose) Polymerases, Research Article, Programmed cell death, Cell Survival, Science, 03 medical and health sciences, Cancer stem cell, Cyclins, Cell Line, Tumor, Breast Cancer, Humans, Cell Proliferation, 030304 developmental biology, Clinical Genetics, Phenylurea Compounds, Cancers and Neoplasms, Biology and Life Sciences, Proteins, AMPK, Cell Biology, Enzyme Activation, 030104 developmental biology, Cancer research, Acetyl-CoA Carboxylase
الوصف: PurposeTriple negative breast cancer (TNBC) is the most lethal and aggressive subtype of breast cancer. AMP-activated protein kinase (AMPK) is a major energy regulator that suppresses tumor growth, and 1-(3-chloro-4-((trifluoromethyl)thio)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea (FND-4b) is a novel AMPK activator that inhibits growth and induces apoptosis in colon cancer. The purpose of this project was to test the effects of FND-4b on AMPK activation, proliferation, and apoptosis in breast cancer with a particular emphasis on TNBC.Materials and methods(i) Estrogen-receptor positive breast cancer (ER+BC; MCF-7, and T-47D), TNBC (MDA-MB-231 and HCC-1806), and breast cancer stem cells were treated with FND-4b for 24h. Immunoblot analysis assessed AMPK, acetyl-CoA carboxylase (ACC), ribosomal protein S6, cyclin D1, and cleaved PARP. (ii) Sulforhodamine B growth assays were performed after treating ER+BC and TNBC cells with FND-4b for 72h. Proliferation was also assessed by counting cells after 72h of FND-4b treatment. (iii) Cell death ELISA assays were performed after treating ER+BC and TNBC cells with FND-4b for 72h.Results(i) FND-4b increased AMPK activation with concomitant decreases in ACC activity, phosphorylated S6, and cyclin D1 in all subtypes. (ii) FND-4b decreased proliferation in all cells, while dose-dependent growth decreases were found in ER+BC and TNBC. (iii) Increases in apoptosis were observed in ER+BC and the MDA-MB-231 cell line with FND-4b treatment.ConclusionsOur findings indicate that FND-4b decreases proliferation for a variety of breast cancers by activating AMPK and has notable effects on TNBC. The growth reductions were mediated through decreases in fatty acid synthesis (ACC), mTOR signaling (S6), and cell cycle flux (cyclin D1). ER+BC cells were more susceptible to FND-4b-induced apoptosis, but MDA-MB-231 cells still underwent apoptosis with higher dose treatment. Further development of FND compounds could result in a novel therapeutic for TNBC.
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd8daaf4084054e5375eb2af0b2a609Test
https://doi.org/10.1101/489179Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....1fd8daaf4084054e5375eb2af0b2a609
قاعدة البيانات: OpenAIRE